Acute Respiratory Distress Syndrome Market Set to Surge as Innovation Meets Rising Global Burden
Acute Respiratory Distress Syndrome (ARDS), a life-threatening condition marked by severe lung inflammation and respiratory failure, is increasingly becoming a focal point of global healthcare systems. With rising cases linked to pneumonia, sepsis, trauma, and lingering effects of COVID-19, the urgency to improve diagnosis and treatment pathways has never been greater. As a result, the global ARDS market is entering a period of accelerated growth driven by innovation, awareness, and expanding healthcare investments.